Directory

>

Eric Valeur

Eric Valeur

VP, Research | Roivant Sciences

Wellesley, Massachusetts, United States

View contact details (it's free)

Eric Valeur

Summary

Eric Valeur is a seasoned R&D executive with over 15 years of experience in the biotechnology and pharmaceutical sectors. As the VP of Research at Roivant Sciences, he has been instrumental in pioneering drug discovery approaches, particularly in the integration of small molecules and innovative modalities like RNA-based therapies and PROTACs. His leadership has led to the establishment of the first New Modalities group in the industry, showcasing his ability to drive disruptive innovation. Eric's extensive background includes roles at major companies like AstraZeneca and Novartis, where he has consistently delivered clinical candidates and transformative technologies. He holds a Ph.D. in Organic Chemistry from The University of Edinburgh and an MBA from Imperial College Business School. Eric's passion for innovation is matched by his commitment to improving patient outcomes through scientific advancement.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Eric Valeur

Work Experience

company logo

VP, Research at

Roivant Sciences

March 2024 - Present

company logo

VP, Head of Drug Discovery at

Roivant Sciences

February 2021 - February 2024

company logo

BaseLaunch incubator selection board member at

Roivant Sciences

August 2021 - December 2023

💼

Head of Platform Research at

Flagship VentureLabs

January 2019 - January 2021

company logo

Director of New Modalities & Innovation at

AstraZeneca

May 2018 - January 2019

company logo

Associate Director, New Modalities Medicinal Chemistry at

AstraZeneca

May 2014 - April 2018

company logo

Flagship Pioneering / AstraZeneca Fellow at

Flagship Pioneering

January 2017 - April 2018

company logo

Project Leader / Team Leader Medicinal Chemistry at

Novartis

January 2009 - April 2014

company logo

Project Leader / Team Leader Medicinal Chemistry at

MERCK ROMANIA SRL

January 2007 - January 2009

💼

Postdoctoral Fellow at

Northern Institute For Cancer Research

February 2006 - January 2007

Logos provided by Logo.dev

Eric Valeur

Education

The University of Edinburgh, Doctor Of Philosophy (Ph.D.)

January 2006

Imperial College Business School, Master Of Business Administration (M.B.A.)

January 2015

Ecole Nationale Supérieure de Chimie de Montpellier, Master Of Science (M.Sc.)

January 2002

University of Montpellier, Master Of Science (M.Sc)

January 2002

Frequently Asked Questions about Eric Valeur

What is Eric Valeur email address?

Eric Valeur's primary email address is *******@roivant.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Eric Valeur work for?

Eric Valeur is a VP, Research at Roivant Sciences.

Where Eric Valeur graduated from?

Eric Valeur holds a degree in Organic Chemistry from The University of Edinburgh.

How can I directly contact Eric Valeur?

To contact Eric Valeur directly, you can use the email address *******@roivant.com. Complete contact information is available upon registration with Muraena.

Is Eric Valeur an immigrant?

Yes, Eric Valeur is an immigrant and currently based in United States

Who is Eric Valeur?

Eric Valeur is a seasoned R&D executive with over 15 years of experience in the biotechnology and pharmaceutical sectors. As the VP of Research at Roivant Sciences, he has been instrumental in pioneering drug discovery approaches, particularly in the integration of small molecules and innovative modalities like RNA-based therapies and PROTACs. His leadership has led to the establishment of the first New Modalities group in the industry, showcasing his ability to drive disruptive innovation. Eric's extensive background includes roles at major companies like AstraZeneca and Novartis, where he has consistently delivered clinical candidates and transformative technologies. He holds a Ph.D. in Organic Chemistry from The University of Edinburgh and an MBA from Imperial College Business School. Eric's passion for innovation is matched by his commitment to improving patient outcomes through scientific advancement.

Eric`s contact details

mail

*******@roivant.com

***********@astrazeneca.com

Colleagues

avatar
Srini Ramanathan

Chief Development Officer

avatar
Paul Davis

Chief Communications Officer

avatar
Richard Pulik

Chief Financial Officer

avatar
Sudhir Penugonda

Executive Director

avatar
Stephanie Lee Griffin

VP, Special Projects, Office of CEO

avatar
Drew Fromkin

Chief Executive Officer

avatar
Shingai Majuru

Vice President, Head of CMC, Small Molecule Development

Keith Haan

Senior Vice President, Investments

avatar
Daniel Patterson

Vice President, Head of CMC, Biologics and Gene Therapies

View Contact details (it's free)
Request Profile Removal